StonvexLoading…
StonvexStonvexStonvexCore line items from DPZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-22 | Annual 2025 2025-12-28 | Q3 2025 2025-09-07 | Q2 2025 2025-06-15 |
|---|---|---|---|---|---|
Revenue | $1.20B | $1.15B | $4.94B | $3.40B | $2.26B |
Operating Income | Not available | $230.36M | $953.97M | $658.31M | $435.14M |
Net Income | Not available | $139.81M | $601.70M | $420.06M | $280.74M |
EPS (Diluted) | $4.29 | $4.13 | $17.57 | $12.22 | $8.14 |
Total Assets | Not available | $1.84B | $1.72B | $1.66B | $1.81B |
Total Liabilities | Not available | Not available | $5.62B | Not available | Not available |
Cash & Equivalents | Not available | $232.92M | $125.67M | $139.73M | $272.86M |
Free Cash Flow OCF − CapEx | Not available | $146.91M | $671.50M | $495.59M | $331.63M |
Shares Outstanding | Not available | 33.82M | 33.63M | 34.37M | 34.48M |